Universal Time: 22:39  |  Local Time: 22:39 (3h GMT)
Select your timezone:

Abstract Session
Kidney Outcomes and Complications 2

Wednesday September 25, 2024 | 13:40 to 15:10
Room: TBD
Track: N/A


Dr. Faissal Shaheen, Saudi Arabia Invited Speaker
Rejection post-transplant

Owen Ng, Australia
Longitudinal assessment of health-related quality of life in patients with chronic kidney disease

Dr. Yasushi Mochizuki, Japan
Clinical study of the importance of IgG level in kidney transplant recipient

Dr. Nida Saleem, Australia
Reported cancer screening practices by healthcare professionals for kidney transplant candidates and recipients

Dr. Mevlut T. Dincer, Turkey
Does de novo malignancy increase the risk of rejection in kidney transplant recipients?

Nuria Montero, Spain
Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: a systematic review and meta-analysis

Michiko Shimada, Japan
Efficacy and safety of 6-month sacubitril/valsartan administration in post-renal transplant patients; possibly contribution to long-term graft survival?

Dr. Hay Me Me, United States
Differences in High and Low Dose Belatacept Conversion Effects in Kidney Transplant Patients

Dr. Antonio Franco Esteve, Spain
Pre-emptive first deceased donor renal transplant: A matched cohort study

Dr. Laia Oliveras, Spain
Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients: a systematic review and meta-analysis

Social Media Promotion Image

right-click to download

© 2024 TTS 2024